Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556473 · ClinicalTrials.gov registry record · Phase 1

F-Tryptophan PET/CT in Human Cancers

A Phase 1 study of Breast Cancer and Rectal Cancer, sponsored by Barbara Ann Karmanos Cancer Institute.

Recruiting
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT05556473 is a Phase 1 study of Breast Cancer and Rectal Cancer that is actively recruiting participants, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 24 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556473, a Phase 1 study of Breast Cancer and Rectal Cancer, is actively recruiting participants, sponsored by Barbara Ann Karmanos Cancer Institute.

RECRUITING
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.

Conditions Studied

Breast Cancer Rectal Cancer Neuroendocrine Tumors Metastatic Brain Tumor Intracranial Glioma

Interventions

  • DRUG 1-(2-[18F]FLUOROETHYL)-L-Tryptophan

Study Locations (1)

Michigan

  • Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-09-29
Est. Completion 2027-12-31
Phase Phase 1

Sponsor

Barbara Ann Karmanos Cancer Institute

139 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05556473

The ClinicalTrials.gov registry entry for NCT05556473 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which 1-(2-[18F]FLUOROETHYL)-L-Tryptophan is the first listed.

NCT05556473 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05556473 about?

NCT05556473 is a clinical study titled "F-Tryptophan PET/CT in Human Cancers". Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue wher...

What is the current status of trial NCT05556473?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-09-29. Estimated completion is 2027-12-31.

What conditions does trial NCT05556473 study?

This clinical trial studies the following conditions: Breast Cancer, Rectal Cancer, Neuroendocrine Tumors, Metastatic Brain Tumor, Intracranial Glioma.

What interventions are being tested in trial NCT05556473?

The interventions under investigation include: 1-(2-[18F]FLUOROETHYL)-L-Tryptophan (DRUG).

Who is sponsoring clinical trial NCT05556473?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05556473 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Rectal Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.